Sfoglia per Autore
Epidemiology of SARS-CoV-2 Infection in Italy Using Real-World Data: Methodology and Cohort Description of the Second Phase of Web-Based EPICOVID19 Study
2009 F. Adorni, N. Jesuthasan, E. Perdixi, A. Sojic, A. Giacomelli, M. Noale, C. Trevisan, M. Franchini, S. Pieroni, L. Cori, C.M. Mastroianni, F. Bianchi, R. Antonelli-Incalzi, S. Maggi, M. Galli, F. Prinelli
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV-infected patients
2012 A. Giacomelli, M. Franzetti, B. Vergani, L. Oreni, M. Morosi, V. Di Cristo, E. Colella, O. Viganò, M. Galli, S. Rusconi
Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens
2014 A. Giacomelli, L. Oreni, M. Franzetti, V. Di Cristo, B. Vergani, M. Morosi, E. Colella, M. Galli, S. Rusconi
An update on integrase inhibitors : new opportunities for a personalized therapy? The NEXTaim Project
2015 M. Andreoni, S. Marcotullio, V. Puro, G. De Carli, G. Tambussi, S. Nozza, A. Gori, S. Rusconi, M.M. Santoro, M. Clementi, C.F. Perno, A. d'Arminio Monforte, F. Maggiolo, A. Castagna, A. De Luca, M. Galli, A. Giacomelli, M. Borderi, G. Guaraldi, A. Calcagno, G. Di Perri, S. Bonora, C. Mussini, A. Di Biagio, M. Puoti, R. Bruno, V. Zuccaro, A. Antinori, P. Cinque, D. Croce, U. Restelli, G. Rizzardini, A. Lazzarin
Factors involved in continuance of atazanavir-based regimens : Results from a cohort of HIV1-positive patients
2016 A. Giacomelli, L. Oreni, M. Franzetti, V. Di Cristo, E. Colella, A.L. Ridolfo, M. Galli, S. Rusconi
Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients
2017 S.E. Salvaggio, A. Giacomelli, F.S. Falvella, M.L. Oreni, P. Meraviglia, C. Atzori, E.G.I. Clementi, M. Galli, S. Rusconi
Successful treatment of sexually acquired acute HCV reinfection with ledipasvir/sofosbuvir in a HIV-infected patient
2017 S. Sollima, S. Antinori, A. Torre, F. Binda, A. Giacomelli, L. Milazzo
Clinical pharmacology in HIV cure research : what impact have we seen?
2018 A. Giacomelli, S. de Rose, S. Rusconi
Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF
2018 D. Cattaneo, D. Minisci, S. Baldelli, C. Mazzali, A. Giacomelli, L. Milazzo, P. Meraviglia, C. Resnati, G. Rizzardini, E. Clementi, M. Galli, C. Gervasoni
RNA viruses and autoimmunity: A short overview
2018 M. Galli, G. Bozzi, A. Giacomelli
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study
2018 J. Gatell, L. Assoumou, G. Moyle, L. Waters, M. Johnson, P. Domingo, J. Fox, E. Martinez, H. Stellbrink, G. Guaraldi, M. Masia, M. Gompels, S. De Wit, E. Florence, S. Esser, F. Raffi, C. Stephan, J. Rockstroh, A. Giacomelli, J. Vera, J. Bernardino, A. Winston, M. Saumoy, J. Gras, C. Katlama, A. Pozniak
Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older
2018 A. Ranzani, L. Oreni, M. Agrò, L. van den Bogaart, L. Milazzo, A. Giacomelli, D. Cattaneo, C. Gervasoni, A.L. Ridolfo
Clinical and genetic determinants of nevirapine plasma trough concentration
2018 A. Giacomelli, S. Rusconi, F.S. Falvella, M.L. Oreni, D. Cattaneo, V. Cozzi, G. Renisi, E. Monge, S. Cheli, E. Clementi, A. Riva, M. Galli, A.L. Ridolfo
Loss of Control of HIV Viremia With OTC Weight-Loss Drugs: A Call for Caution?
2018 D. Cattaneo, A. Giacomelli, C. Gervasoni
Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients : Potential implications for clinical practice
2018 D. Cattaneo, S. Baldelli, C. Resnati, A. Giacomelli, P. Meraviglia, D. Minisci, N. Astuti, L. Ridolfo Anna, V. De Socio Giuseppe, E. Clementi, M. Galli, C. Gervasoni
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients
2018 A. Ciccullo, G. Baldin, A. Capetti, S. Rusconi, G. Sterrantino, G. D'Ettorre, M. Colafigli, S. Modica, F. Lagi, A. Giacomelli, M.V. Cossu, S. Restelli, A. De Luca, S. Di Giambenedetto
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy
2018 A. Giacomelli, A. Riva, F.S. Falvella, M.L. Oreni, D. Cattaneo, S. Cheli, G. Renisi, V. Di Cristo, A. Lupo, E. Clementi, S. Rusconi, M. Galli, A.L. Ridolfo
HCV and drug addiction in the historical scenario of infection entry in Italy
2018 M. Galli, A. Ridolfo, L.V. Denbogaart, C. Negri, A. Giacomelli
HCV and immigration in Italy
2018 M. Galli, A. Ridolfo, L. van denBogaart, C. Negri, A. Giacomelli
A review of Chagas disease in Italy and the study's contribution of Italian researchers
2019 S. Antinori, A. Ridolfo, A. Giacomelli, C.M. Bonazzetti, M. Corbellino, M. Galli
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile